Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytokines in dementias.

Elisabeth Tarkowski1

  • 1Department of Rheumatology, University of Göteborg, Guldhedsgatan 10, S-413 46 Göteborg, Sweden. elisabeth.tarkowski@immuno.gu.se

Current Drug Targets. Inflammation and Allergy
|October 17, 2003
PubMed
Summary

Inflammation, involving cytokines, plays a role in Alzheimer's disease (AD) and vascular dementia (VAD). These inflammatory molecules may amplify shared pathological changes like amyloid buildup and white matter damage in both neurodegenerative conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cognitive dysfunction and physical activity after stroke: the Gothenburg cognitive stroke study in the elderly.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2011
Same author

Cognitive function and improvement of balance after stroke in elderly people: the Gothenburg cognitive stroke study in the elderly.

Disability and rehabilitation·2011
Same author

Cerebral pattern of pro- and anti-inflammatory cytokines in dementias.

Brain research bulletin·2003
Same author

Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia.

Neurobiology of aging·2002

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Limited knowledge exists on the inflammatory components in Alzheimer's disease (AD) and vascular dementia (VAD).
  • Recent findings indicate the presence of inflammatory cytokines in the cerebrospinal fluid (CSF) of patients with dementia.
  • Distinct initial triggers in AD and VAD may converge on similar cytokine production pathways following neuronal injury.

Purpose of the Study:

  • To review the role of pro-inflammatory and anti-inflammatory cytokines in dementia.
  • To explore the impact of cytokines on glia cell activation, amyloidogenesis, vascular changes, white matter damage, and neurodegeneration.

Main Methods:

  • Review of existing clinical studies and scientific literature.
  • Analysis of the proposed mechanisms of cytokine involvement in dementia pathogenesis.
  • Synthesis of evidence supporting shared inflammatory pathways in AD and VAD.

Main Results:

  • Cytokines released in the central nervous system (CNS) may act similarly in AD and VAD.
  • Cytokines can amplify pathological changes including amyloidogenesis, vascular amyloid accumulation, white matter lesions, and angiogenesis.
  • Clinical studies show overlapping pathologies, such as white matter infarcts in AD and senile plaques in VAD.

Conclusions:

  • Cytokine-mediated inflammation is a significant factor in the pathogenesis of both AD and VAD.
  • Shared inflammatory cascades contribute to common neuropathological features observed in these dementia types.
  • Understanding cytokine roles is crucial for developing targeted therapies for dementia.

Related Experiment Videos